Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,126.00p on 11-11-2025 at 06:00:01
Change 0.00p 0%
Buy 13,500.00p
Sell 12,600.00p
Last Trade: Unknown 85.00 at 13,082.99767p
Day's Volume: 0
Last Close: 13,126.00p
Open: 0.00p
ISIN: GB0009895292
Day's Range 0.00p - 0.00p
52wk Range: 9,574.00p - 13,206.00p
Market Capitalisation: £203.49b
VWAP: 0.00p
Shares in Issue: 1.55b

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 85 13,082.99767p Currency Conversion
Negotiated Trade
OTC Trade
17:33:15 - 10-Nov-25
Unknown* 90,573 12,904.00p OTC Trade
17:11:37 - 10-Nov-25
Unknown* 90,573 12,904.00p OTC Trade
17:11:36 - 10-Nov-25
Buy* 30 13,126.00p SI Trade
Negotiated Trade
16:48:37 - 10-Nov-25
Buy* 56,967 13,126.00p SI Trade
16:36:32 - 10-Nov-25
Buy* 544 13,126.00p SI Trade
16:35:02 - 10-Nov-25
Buy* 180 13,126.00p SI Trade
16:35:02 - 10-Nov-25
Buy* 1,869 13,126.00p SI Trade
16:35:02 - 10-Nov-25
Buy* 10,288 13,126.00p SI Trade
16:35:02 - 10-Nov-25
Buy* 4,619 13,126.00p SI Trade
16:35:02 - 10-Nov-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Nov 2025 (Tue) 13,126.00 13,126.00 13,126.00 13,126.00 0
10th Nov 2025 (Mon) 12,904.00 13,206.00 12,840.00 13,126.00 3,313,114
7th Nov 2025 (Fri) 12,788.00 12,938.00 12,714.00 12,900.00 3,536,318
6th Nov 2025 (Thu) 12,570.00 12,994.00 12,330.00 12,834.00 3,100,521
5th Nov 2025 (Wed) 12,528.00 12,596.00 12,436.00 12,450.00 1,818,390
4th Nov 2025 (Tue) 12,448.00 12,528.00 12,242.00 12,528.00 1,233,294
3rd Nov 2025 (Mon) 12,546.00 12,584.00 12,352.00 12,364.00 1,847,968
31st Oct 2025 (Fri) 12,562.00 12,584.00 12,424.00 12,470.00 1,088,828
30th Oct 2025 (Thu) 12,456.00 12,556.00 12,366.00 12,546.00 1,214,406
29th Oct 2025 (Wed) 12,500.00 12,684.00 12,424.00 12,560.00 946,472
28th Oct 2025 (Tue) 12,586.00 12,708.00 12,406.00 12,406.00 1,501,103
27th Oct 2025 (Mon) 12,530.00 12,616.00 12,446.00 12,546.00 1,464,674
24th Oct 2025 (Fri) 12,530.00 12,582.00 12,418.00 12,532.00 1,528,688
23rd Oct 2025 (Thu) 12,432.00 12,566.00 12,432.00 12,496.00 1,297,487
22nd Oct 2025 (Wed) 12,398.00 12,628.00 12,382.00 12,540.00 4,968,617
21st Oct 2025 (Tue) 12,468.00 12,550.00 12,442.00 12,474.00 1,399,159
20th Oct 2025 (Mon) 12,668.00 12,712.00 12,564.00 12,564.00 1,245,234
17th Oct 2025 (Fri) 12,522.00 12,574.00 12,362.00 12,558.00 1,792,038
16th Oct 2025 (Thu) 12,456.00 12,610.00 12,366.00 12,554.00 1,378,035
15th Oct 2025 (Wed) 12,684.00 12,700.00 12,434.00 12,644.00 1,646,096
14th Oct 2025 (Tue) 12,724.00 12,808.00 12,642.00 12,738.00 2,583,056
13th Oct 2025 (Mon) 12,830.00 12,908.00 12,610.00 12,724.00 1,233,495
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
10th Nov 2025 3:00 pm RNS Director/PDMR Shareholding
6th Nov 2025 7:00 am RNS 9M and Q3 2025 results
3rd Nov 2025 4:00 pm RNS Result of General Meeting
3rd Nov 2025 3:00 pm RNS Total Voting Rights
28th Oct 2025 7:05 am RNS Director Declaration
28th Oct 2025 7:00 am RNS Koselugo (selumetinib) approved in the EU
22nd Oct 2025 7:00 am RNS Tezspire Approved in EU for CRSwNP
20th Oct 2025 7:05 am RNS US FDA Approves Tezspire in CRSwNP
20th Oct 2025 7:00 am RNS Positive CHMP opinion for subcutaneous Saphnelo
13th Oct 2025 7:00 am RNS Agreement with US Govt to lower medicine prices
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca says Baxdrostat reduces 24-hour systolic blood pressure

10th Nov 2025 04:32

(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically significant reduction in the systolic blood pressure of patients with resistant hypertension. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Weir; UBS ups British Land

7th Nov 2025 10:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: FTSE 100 slips amid BoE rate hold, fresh US falls

6th Nov 2025 16:59

(Alliance News) - The FTSE 100 fell on Thursday as the Bank of England left interest rates unchanged in a tight vote and investors weighed a deluge of earnings from leading blue-chip names. Read More

LONDON MARKET OPEN: Stocks steady before BoE amid barrage of earnings

6th Nov 2025 09:09

(Alliance News) - Stock prices in London opened steady on Thursday amid a delude of earnings, as investors focus on a finely balanced interest rate decision from the Bank of England. Read More

AstraZeneca backs guidance as third quarter sales beat expectations

6th Nov 2025 08:28

(Alliance News) - AstraZeneca PLC on Thursday said a strong performance in 2025 so far, with third quarter sales ahead of forecast, leaves it well-placed to sustain growth through 2026. Read More

See more Astrazeneca news
FTSE 100 Latest
Value9,787.15
Change0.00

Login to your account

Forgot Password?

Not Registered